Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy Ratner

Showing results (91-100 of 147) with videos related to

Pageof 15
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2019
Targeted Inhibition of the Dual Specificity Phosphatases DUSP1 and DUSP6 Suppress MPNST Growth via JNKAnnmarie Ramkissoon, Katherine E Chaney, David Milewski, et al.
Cell Reports|September 17, 2013
Nf1 loss and Ras hyperactivation in oligodendrocytes induce NOS-driven defects in myelin and vasculatureDebra A Mayes, Tilat A Rizvi, Haley Titus-Mitchell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2010
Gene expression analysis identifies potential biomarkers of neurofibromatosis type 1 including adrenomedullinTrent R Hummel, Walter J Jessen, Shyra J Miller, et al.
Sarcoma|January 16, 2013
Conditional Inactivation of Pten with EGFR Overexpression in Schwann Cells Models Sporadic MPNSTVincent W Keng, Adrienne L Watson, Eric P Rahrmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2012
Ras-driven transcriptome analysis identifies aurora kinase A as a potential malignant peripheral nerve sheath tumor therapeutic targetAmi V Patel, David Eaves, Walter J Jessen, et al.
Oncotarget|April 1, 2014
Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicityAdrienne L Watson, Leah K Anderson, Andrew D Greeley, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 1, 2020
A molecular basis for neurofibroma-associated skeletal manifestations in NF1Yun Ma, Andrea M Gross, Eva Dombi, et al.
Acta Neuropathologica|October 31, 2019
NF1 patient missense variants predict a role for ATM in modifying neurofibroma initiationYanan Yu, Kwangmin Choi, Jianqiang Wu, et al.
Cancer Research|October 11, 2017
A Collaborative Model for Accelerating the Discovery and Translation of Cancer TherapiesOphélia Maertens, Mila E McCurrach, Benjamin S Braun, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 27, 2023
Combining SOS1 and MEK Inhibitors in a Murine Model of Plexiform Neurofibroma Results in Tumor ShrinkageMark Jackson, Niousha Ahmari, Jianqiang Wu, et al.
Pageof 15

Showing results (91-100 of 147) with videos related to

Sort By:
Pageof 15
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2019
Targeted Inhibition of the Dual Specificity Phosphatases DUSP1 and DUSP6 Suppress MPNST Growth via JNKAnnmarie Ramkissoon, Katherine E Chaney, David Milewski, et al.
Cell Reports|September 17, 2013
Nf1 loss and Ras hyperactivation in oligodendrocytes induce NOS-driven defects in myelin and vasculatureDebra A Mayes, Tilat A Rizvi, Haley Titus-Mitchell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2010
Gene expression analysis identifies potential biomarkers of neurofibromatosis type 1 including adrenomedullinTrent R Hummel, Walter J Jessen, Shyra J Miller, et al.
Sarcoma|January 16, 2013
Conditional Inactivation of Pten with EGFR Overexpression in Schwann Cells Models Sporadic MPNSTVincent W Keng, Adrienne L Watson, Eric P Rahrmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2012
Ras-driven transcriptome analysis identifies aurora kinase A as a potential malignant peripheral nerve sheath tumor therapeutic targetAmi V Patel, David Eaves, Walter J Jessen, et al.
Oncotarget|April 1, 2014
Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicityAdrienne L Watson, Leah K Anderson, Andrew D Greeley, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 1, 2020
A molecular basis for neurofibroma-associated skeletal manifestations in NF1Yun Ma, Andrea M Gross, Eva Dombi, et al.
Acta Neuropathologica|October 31, 2019
NF1 patient missense variants predict a role for ATM in modifying neurofibroma initiationYanan Yu, Kwangmin Choi, Jianqiang Wu, et al.
Cancer Research|October 11, 2017
A Collaborative Model for Accelerating the Discovery and Translation of Cancer TherapiesOphélia Maertens, Mila E McCurrach, Benjamin S Braun, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 27, 2023
Combining SOS1 and MEK Inhibitors in a Murine Model of Plexiform Neurofibroma Results in Tumor ShrinkageMark Jackson, Niousha Ahmari, Jianqiang Wu, et al.
Pageof 15